Risk factors
Eledon Pharmaceuticals (ELDN) risk factors
Item 1A of every Eledon Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors43 risks2 new1 dropped4 reworded
Eledon added risks concerning massive share dilution from recent private placements and offerings, alongside patent portfolio maintenance challenges. The company continues to face capital raises, regulatory uncertainties under the Inflation Reduction Act, and clinical-stage manufacturing hurdles.
Filed Mar 19, 2026 - FY2024 10-K risk factors42 risks
Clinical-stage biopharmaceutical company focused on developing its lead drug candidate, tegoprubart.
Filed Mar 20, 2025